Three biosimilars by Celltrion near EU approval following CHMP endorsement

Pallavi Madhiraju- December 16, 2024 0

Celltrion, a leading South Korean biopharmaceutical company, has received positive opinions from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) ... Read More

Hasten Biopharmaceutical buys asset rights for 14 branded products from Celltrion

Pallavi Madhiraju- July 1, 2024 0

In a significant move, CBC Group, Asia's largest healthcare-dedicated asset management firm headquartered in Singapore, announced that its portfolio company, Hasten Biopharmaceutical, has successfully acquired ... Read More